EFFECTS OF CHRONIC ADMINISTRATION OF HUPERZINE A ON MEMORY IN GUINEA PIGS

REFERENCES

• Kozikowski A. P., Xia Y., Reddy E. R., Tuckmantel W., Hanin I., Tang X. C. Synthesis of Huperzine A and its Analogues and their Anticholinesterase Activity. J. Org. Chem. 1991; 56: 4633–4645
   Google Scholar
• Ashani Y., Peggins J. O., III, Doctor B. P. Mechanism of Inhibition of Cholinesterases by Huperzine A. Biochem. Biophys. Res. Comm. 1992; 184: 719–726
   PubMed Web of Science ®Google Scholar
• Bartus R. T., Dean R. L., III, Beer B., Lippa A. S. The Cholinergic Hypothesis of Geriatric Memory Dysfunction. Science 1982; 217: 408–417
   PubMed Web of Science ®Google Scholar
• Wilcock G. K., Tsiri M. M., Bowen D. M. Alzheimer's Disease. Correlation of Cortical Choline Acetyltransferase Activity with the Severity of Dementia and Histological Abnormalities. J. Neurol. Sci. 1982; 57: 407–417
   PubMed Web of Science ®Google Scholar
• Davidson M., Stern R. G., Bierer L. M. Cholinergic Strategies in the Treatment of Alzheimer's Disease. Acta Psychiatr. Scand. Suppl. 1991; 366: 47–51
   PubMedGoogle Scholar
• Summers W. K., Majovski L. V., Marsh G. M. Oral Tetrahydroaminoacridine in Long-term Treatment of Senile Dementia, Alzheimer Type. N. N. Engl. J. Med. 1986; 315: 1241–1245
   PubMed Web of Science ®Google Scholar
• Thal L. J., Masur D. M., Blau A. D. Chronic Oral Physostigmine Without Lecithin Improves Memory in Alzheimer's Disease. J. Am. Geriatr. Soc. 1989; 37: 42–48
   PubMed Web of Science ®Google Scholar
• Ames D. J., Bhathal P. S., Davies B. M., Fraser J. R. E. Hepatotoxicity of Tetrahydroacridine. Lancet 1988; 1: 887
   PubMed Web of Science ®Google Scholar
• Yoshida S., Suzuki N. Antiamnesic and Cholinomimetic Side-effects of the Cholinesterase Inhibitors, Physostigmine, Tacrine and NIK-247 in Rats. Eur. J. Pharmacol. 1993; 250: 117–124
   PubMed Web of Science ®Google Scholar
• Qian B. C., Wang M., Zhou Z.-F., Chen K., Zhou R.-R., Chen G.-S. Pharmacokinetics of Tablet Huperzine A in Six Volunteers. Acta Pharmacol. Sin. 1995; 16: 396–398
   PubMed Web of Science ®Google Scholar
• Laganiere S., Corey J., Tang X.-C., Wulfer E., Hanin H. Acute and Chronic Studies with the Anticholinesterase Huperzine A: Effect on Central Nervous System Cholinergic Parameters. Neuropharmacology 1991; 30: 763–768
   PubMed Web of Science ®Google Scholar
• Hallak M., Giacobini E. Physostigmine, Tacrine, and Metrifonate: Effect of Multiple Doses on Acetylcholine Metabolism in the Brain. Neuropharmacology 1989; 28: 199–206
   PubMed Web of Science ®Google Scholar
• Gordon J. J., Leadbeater L., Maidment M. P. The Protection of Animals Against Organophosphate Poisoning by Pretreatment with a Carbamate. Toxicol. Appl. Pharmacol. 1978; 43: 207–216
   PubMed Web of Science ®Google Scholar
• Grunwald J., Raveh L., Doctor B. P., Ashani Y. Huperzine A as a Pretreatment Candidate Drug Against Nerve Agent Toxicity. Life Sci. 1994; 54: 991–997
   PubMed Web of Science ®Google Scholar
• Tang X. C., De Sarno P., Sugaya K., Giacobini E. Effect of Huperzine A, a New Cholinesterase Inhibitor, on the Central Cholinergic System of the Rat. J. Neurosci. Res. 1989; 24: 276–285
   PubMed Web of Science ®Google Scholar
• Lallement G., Veyret J., Masqueliez C., Aubriot S., Burckhart M.-F., Baubichon D. Efficacy of Huperzine in Preventing Soman-induced Seizures, Neuropathological Changes and Lethality. Fundam. Clin. Pharmacol. 1997; 11: 387–394
   PubMed Web of Science ®Google Scholar
• Ashani Y., Grunwald J., Alkalai D., Cohen G., Raveh L. Studies with Huperzine A, a New Candidate in the Research of Prophylaxis Against Nerve Agent. Proc. Med. Defence Biosci. Rev. 1996; 105–110
   Google Scholar
• Liu J., Zang H. Y., Tang X. C., Wang B., He X. C., Bai D. L. Effects of Synthetic (−)-Huperzine A on Cholinesterase Activities and Mouse Water Maze Performance. Acta Pharmacol. Sin. 1998; 19: 413–416
   PubMed Web of Science ®Google Scholar
• Xiong Z. Q., Tang X. C. Effect of Huperzine A, a Novel Acetylcholinesterase Inhibitor, on Radial Maze Performance in Rats. Pharmacol. Biochem. Behav. 1995; 51: 415–419
   PubMed Web of Science ®Google Scholar
• Wang T., Tang X. C. Reversal of Scopolamine-induced Deficits in Radial Maze Performance by (−)-Huperzine A: Comparison with E2020 and Tacrine. Eur. J. Pharmacol. 1998; 349: 137–142
   PubMed Web of Science ®Google Scholar
• Xiong Z. Q., Han Y. F., Tang X. C. Huperzine A Ameliorates the Spatial Working Memory Impairments Induced by AF64. NeuroReport 1995; 6: 2221–2224
   PubMed Web of Science ®Google Scholar
• Cheng D. H., Tang X. C. Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities. Pharmacol. Biochem. Behav. 1998; 60: 377–386
   PubMed Web of Science ®Google Scholar
• Xiong Z. Q., Cheng D. H., Tang X. C. Effects of Huperzine A on Nucleus Basalis Magnocellularis Lesion-induced Spatial Working Memory Deficit. Acta Pharmacol. Sin. 1998; 19: 128–132
   Web of Science ®Google Scholar
• Ye J. W., Cai J. X., Wang L. M., Tang X. C. Improving Effects of Huperzine A on Spatial Working Memory in Aged Monkeys and Young Adult Monkeys with Experimental Cognitive Impairment. J. Pharmacol. Exp. Ther. 1999; 288: 814–819
   PubMed Web of Science ®Google Scholar
• Sun Q.-Q., Xu S.-S., Pan J.-L., Guo H.-M., Cao W.-Q. Huperzine-A Capsules Enhance Memory and Learning Performance in 34 Pairs of Matched Adolescent Students. Acta Pharmacol. Sin. 1999; 20: 601–603
   Web of Science ®Google Scholar
• Xu S. S., Gao Z. X., Weng Z., Du Z. M., Xu W. A., Yang J. S., Zhang M. L., Tong Z. H., Fang Y. S., Chai X. S., Li S. L. Efficacy of Tablet Huperzine-A on Memory, Cognition, and Behavior in Alzheimer's Disease. Acta Pharmacol. Sin. 1995; 16: 391–395
   PubMed Web of Science ®Google Scholar
• Koplovitz I., Gresham V., Kaminski A., Stewart J. Evaluation of the Toxicity and Treatment of GF Poisoning in Rhesus Monkeys. Proc. NATO RSG 3 Panel VIII 1991; 632–643
   Google Scholar
• Morris R. G. M. Developments of a Water-maze Procedure for Studying Spatial Learning in the Rat. J. Neurosci. Meth. 1984; 11: 47–60
   PubMed Web of Science ®Google Scholar
• Wetherell J. Continuous Administration of Low Dose Rates of Physostigmine and Hyoscine to Guinea-Pigs Prevents the Toxicity and Reduces the Incapacitation Produced by Soman Poisoning. J. Pharm. Pharmacol. 1994; 46: 1023–1028
   PubMed Web of Science ®Google Scholar
• Ellman G. L., Courtney K. D., Andres V., Featherstone R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein Measurement with the Folin Phenol Reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Marighetto A., Micheau J., Jaffard R. Relationships Between Testing-induced Alterations of Hippocampal Cholinergic Activity and Memory Performance on Two Spatial Tasks in Mice. Behav. Brain Res. 1993; 56: 133–144
   PubMed Web of Science ®Google Scholar
• Tees R. C., Mohammadi E. The Effects of Neonatal Choline Dietary Supplementation on Adult Spatial and Configural Learning and Memory in Rats. Dev. Psychobiol. 1999; 35: 226–240
   PubMed Web of Science ®Google Scholar
• Shannon H. E., Bemis K. G., Hendrix J. C., Ward J. S. Interactions Between Scopolamine and Muscarinic Cholinergic Agonists or Cholinesterase Inhibitors on Spatial Alternation Performance in Rats. J. Pharmacol. Exp. Ther. 1990; 255: 1071–1077
   PubMed Web of Science ®Google Scholar
• Murray T. K., Cross A. J., Green A. R. Reversal by Tetrahydroaminoacridine of Scopolamine-Induced Memory and Performance Deficits in Rats. Psychopharmacology 1991; 105: 134–136
   PubMed Web of Science ®Google Scholar
• Sarter M., Hagan J., Dudchenko P. Behavioral Screening for Cognition Enhancers: from Indiscriminate to Valid Testing: Part II. Psychopharmacology 1992; 107: 461–473
   PubMed Web of Science ®Google Scholar
• Frontali M., Amorico L., De Acetis L., Bignami G. A Pharmacological Analysis of Processes Underlying Differential Responding: a Review and Further Experiments with Scopolamine, Amphetamine, Lysergic Acid Diethylamide (LSD-25), Chlordiazepoxide, Physostigmine and Chlorpromazine. Behav. Biol. 1976; 18: 1–74
   PubMedGoogle Scholar
• Riekkinen P., Jr., Aaltonen M., Sirviö J., Riekkinen M. Tetrahydroaminoacridine Alleviates Medial Septal Lesion-Induced and Age-related Spatial Reference but not Working Memory Deficits. Physiol. Behav. 1991a; 49: 1147–1152
   PubMed Web of Science ®Google Scholar
• Riekkinen P., Jr., Riekkinen M., Lahtinen H., Sirviö J., Valjakka A., Riekkinen P. Tetrahydroaminoacridine Improves Passive Avoidance Retention Defects Induced by Aging and Medial Septal Lesion but not by Fimbria-Fornix Lesion. Brain Res. Bull. 1991b; 27: 587–594
   PubMed Web of Science ®Google Scholar
• Jackson J. J., Soliman M. R. I. Effects of Tacrine (THA) on Spatial Reference Memory and Cholinergic Enzymes in Specific Rat Brain Regions. Life Sci. 1996; 58: 47–54
   PubMed Web of Science ®Google Scholar
• Keseberg U., Schmidt W. J. Tetrahydroaminoacridine Attenuates Dizocilpine-induced Behavioural Changes. Behav. Brain Res. 1993; 53: 113–118
   PubMed Web of Science ®Google Scholar
• Philippens I. H. C. H. M., Wolthuis O. L., Busker R. W., Langerberg J. P., Melchers B. P. C. Side Effects of Physostigmine as a Pretreatment in Guinea Pigs. Pharmacol. Biochem. Behav. 1996; 55: 99–105
   PubMed Web of Science ®Google Scholar
• Philippens I. H. C. H. M., Busker R. W., Wolthuis O. L., Olivier B., Bruijnzeel P. L. B., Melchers B. P. C. Subchronic Physostigmine Pretreatment in Guinea Pigs: Effective Against Soman and Without Side Effect. Pharmacol. Biochem. Behav. 1997; 59: 1061–1067
   Web of Science ®Google Scholar
• Wolthuis O. L., Groen B., Busker R. W., Van Helden H. P. M. Effects of Low Doses of Cholinesterase Inhibitors on Behavioral Performance of Robot-tested Marmosets. Pharmacol. Biochem. Behav. 1995; 51: 443–456
   PubMed Web of Science ®Google Scholar
• Lim D. K., Hoskins B., Ho I. K. Evidence for the Involvement of Presynaptic Cholinergic Functions in Tolerance to Diisopropylfluorophosphate. Toxicol. Apl. Pharmacol. 1987; 90: 465–476
   PubMed Web of Science ®Google Scholar
• Philippens I. H. C. H. M., Melchers B. P. C., Wolthuis O. L. Active Avoidance Behaviour in Guinea Pigs: Effects of Physostigmine and Scopolamine. Pharmacol. Biochem. Behav. 1992; 42: 285–289
   PubMed Web of Science ®Google Scholar